Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Metabolic update: better defining lipodystrophy and treating insulin resistance.
A large case-control study finds that lipoatrophy is the predominant fat abnormality in HIV-infected patients, and a small randomized, placebo-controlled study finds benefit for rosiglitazone for insulin resistance.
Currier
J
J
D016022:Case-Control Studies; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D008297:Male; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D014280:Triglycerides; D000077154:Rosiglitazone